The global newborn screening market is witnessing an admirable growth due to the medical advancements, high number of research activities in this segment and high awareness among people about newborn screening. In addition, newborn screening market is highly developing due to the participation of many new players in this market. New entrants are focusing on new technologies and launching of new product into the market. However lack of awareness, lack of trained professionals and lack of infrastructure are expected to hinder the growth of newborn screening market.
Newborn screening is a practice of screening infants soon after birth for certain harmful and potentially fatal diseases that are not apparent at birth. Majority of newborn screening tests are performed by evaluating metabolites and enzyme activity in blood samples that are collected on specified filter paper. Metabolic and other inherited disorders can hamper an infant's normal mental and physical development in a number of ways. By carrying out a blood test, doctors can inform whether newborns have certain conditions that could lead to disease or impairment in future to their health. Infants who are screened positive undergo additional testing to confirm if they are truly affected with a disease. Follow-up testing is then carried out by geneticists and pediatrician .
Request a PDF Brochure with Report Analysis:
Newborn Screening is an effective public health movement that targets to identify a number of congenital disorders in newborn children. Many of the disorders if not treated early could result in high mortality and morbidity rates. Newborn screening helps in detection of serious and life threatening diseases such as sickle cell disease, biotinidase deficiency, congenital adrenal hyperplasia, congenital hypothyroidism, galactosemia, cystic fibrosis etc. National Institute Of Health had launched a genomic sequencing and newborn screening disorders research program in 2013 to explore the implications, limitations and challenges associated genomic sequencing in newborn babies.
In Many regions healthcare professionals have started to screen infants for hearing loss and congenital heart defects . Screening programs are mainly run by national or state governing bodies with the goal to screen all infants born in the jurisdiction. The number of diseases to be screened is decided by each jurisdiction, and can differ greatly. Newborn screening was initiated in the U.S. as a public health program. The first disorder targeted for newborn screening was phenylketonuria (PKU) that is now implemented in rest of the world.
Geographically, the newborn screening market is segmented into four major regions: North America, Europe, Asia-Pacific and Rest of the World (RoW). In terms of geography, North America accounts for the highest market, followed by Europe due to highly developed healthcare industry, high disposable income and increased government support. However, Asia Pacific market is also witnessing a very positive growth due to high rate of development in healthcare industry, investment by major players and increasing government initiative for the control of newborn diseases and developing medical tourism industry.
Some of the key players operating in newborn screening market are Bio-Rad Laboratories, BioTek Instruments, Inc., GE Life Sciences, Masimo Corporation, Natus Medical Inc., PerkinElmer Inc. and ZenTech S.A.
Browse Full Research Report on Newborn Screening Market:
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR Syndicated Research report covers a different sector - such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
Browse market research blog: